These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 25585053
1. Impact of boronate capping groups on biological characteristics of novel (99m)Tc(III) complexes [(99m)TcCl(CDO)(CDOH)2B-R] (CDOH2 = cyclohexanedione dioxime). Yang Y, Zheng Y, Tomaselli E, Fang W, Liu S. Bioconjug Chem; 2015 Feb 18; 26(2):316-28. PubMed ID: 25585053 [Abstract] [Full Text] [Related]
2. Novel 99mTc(III)-azide complexes [99mTc(N3)(CDO)(CDOH)2B-R] (CDOH2=cyclohexanedione dioxime) as potential radiotracers for heart imaging. Liu M, Zheng Y, Avcibasi U, Liu S. Nucl Med Biol; 2016 Nov 18; 43(11):732-741. PubMed ID: 27632344 [Abstract] [Full Text] [Related]
3. Novel 99mTc(III) Complexes [99mTcCl(CDO)(CDOH)2B-R] (CDOH2 = Cyclohexanedione Dioxime) Useful as Radiotracers for Heart Imaging. Liu M, Fang W, Liu S. Bioconjug Chem; 2016 Nov 16; 27(11):2770-2779. PubMed ID: 27737549 [Abstract] [Full Text] [Related]
4. 99mTc-3Cboroxime: a novel 99mTc(iii) complex [99mTcCl(CDO)(CDOH)2B-3C] (CDOH2 = cyclohexanedione dioxime; 3C-B(OH)2 = 3-(carbamoylphenyl)boronic acid) with high heart uptake and long myocardial retention. Liu M, Liu S. Dalton Trans; 2017 Oct 31; 46(42):14509-14518. PubMed ID: 29087405 [Abstract] [Full Text] [Related]
5. Effect of co-ligands on chemical and biological properties of (99m)Tc(III) complexes [(99m)Tc(L)(CDO)(CDOH)2BMe] (L=Cl, F, SCN and N3; CDOH2=cyclohexanedione dioxime). Zheng Y, Ji S, Tomaselli E, Ernest C, Freiji T, Liu S. Nucl Med Biol; 2014 Oct 31; 41(10):813-24. PubMed ID: 25169135 [Abstract] [Full Text] [Related]
6. Sulfonyl-Containing Boronate Caps for Optimization of Biological Properties of 99mTc(III) Radiotracers [99mTcCl(CDO)(CDOH)2B-R] (CDOH2 = Cyclohexanedione Dioxime). Zhao ZQ, Liu M, Fang W, Liu S. J Med Chem; 2018 Jan 11; 61(1):319-328. PubMed ID: 29186661 [Abstract] [Full Text] [Related]
7. Novel Approach for 99mTc-Labeling of Red Blood Cells: Evaluation of 99mTc-4SAboroxime as a Blood Pool Imaging Agent. Liu M, Zhao ZQ, Fang W, Liu S. Bioconjug Chem; 2017 Dec 20; 28(12):2998-3006. PubMed ID: 29148726 [Abstract] [Full Text] [Related]
8. 99mTc-3SPboroxime: A neutral 99mTc(III) radiotracer with high heart uptake and long myocardial retention. Xi XY, Wang L, Hsu B, Zhao ZQ, Liu S, Fang W. J Nucl Cardiol; 2021 Dec 20; 28(6):2687-2696. PubMed ID: 32180138 [Abstract] [Full Text] [Related]
9. Myocardial kinetics of technetium-99m teboroxime in the presence of postischemic injury, necrosis and low flow reperfusion. Beanlands RS, DeKemp RA, Harmsen E, Veinot JP, Hartman NG, Ruddy TD. J Am Coll Cardiol; 1996 Aug 20; 28(2):487-94. PubMed ID: 8800130 [Abstract] [Full Text] [Related]
11. Evaluation of novel cationic (99m)Tc-nitrido complexes as radiopharmaceuticals for heart imaging: improving liver clearance with crown ether groups. Liu S, He Z, Hsieh WY, Kim YS. Nucl Med Biol; 2006 Apr 20; 33(3):419-32. PubMed ID: 16631092 [Abstract] [Full Text] [Related]
12. Synthesis and biologic evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties. Boschi A, Uccelli L, Bolzati C, Duatti A, Sabba N, Moretti E, Di Domenico G, Zavattini G, Refosco F, Giganti M. J Nucl Med; 2003 May 20; 44(5):806-14. PubMed ID: 12732683 [Abstract] [Full Text] [Related]
13. Evaluation of novel cationic 99mTc(I)-tricarbonyl complexes as potential radiotracers for myocardial perfusion imaging. He Z, Hsieh WY, Kim YS, Liu S. Nucl Med Biol; 2006 Nov 20; 33(8):1045-53. PubMed ID: 17127179 [Abstract] [Full Text] [Related]
14. Rapid hepatic clearance of 99mTc-TMEOP: a new candidate for myocardial perfusion imaging. Goethals LR, Santos I, Caveliers V, Paulo A, De Geeter F, Lurdes PG, Fernandes C, Lahoutte T. Contrast Media Mol Imaging; 2011 Nov 20; 6(4):178-88. PubMed ID: 21861278 [Abstract] [Full Text] [Related]
15. Preliminary report of SPECT imaging with Tc-99m teboroxime in ischemic heart disease. Drane WE, Keim S, Strickland P, Tineo A, Nicole M. Clin Nucl Med; 1992 Mar 20; 17(3):215-25. PubMed ID: 1611794 [Abstract] [Full Text] [Related]
16. Kit formulated asialoglycoprotein receptor targeting tracer based on copolymer for liver SPECT imaging. Liu C, Guo Z, Zhang P, Song M, Zhao Z, Wu X, Zhang X. Nucl Med Biol; 2014 Aug 20; 41(7):587-93. PubMed ID: 24815356 [Abstract] [Full Text] [Related]
17. Tc-99m-N-MPO: novel cationic Tc-99m radiotracer for myocardial perfusion imaging. Kim YS, Wang J, Broisat A, Glover DK, Liu S. J Nucl Cardiol; 2008 Aug 20; 15(4):535-46. PubMed ID: 18674722 [Abstract] [Full Text] [Related]
18. Clinical experience with technetium-99m teboroxime, a neutral, lipophilic myocardial perfusion imaging agent. Johnson LL, Seldin DW. Am J Cardiol; 1990 Oct 16; 66(13):63E-67E. PubMed ID: 2220625 [Abstract] [Full Text] [Related]
19. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with 99mTc(I) Tricarbonyl Complex. Ku A, Chan C, Aghevlian S, Cai Z, Cescon D, Bratman SV, Ailles L, Hedley DW, Reilly RM. Mol Pharm; 2019 Aug 05; 16(8):3559-3568. PubMed ID: 31242384 [Abstract] [Full Text] [Related]
20. Biodistribution characteristics and SPECT imaging of (99m)Tc-RET and (99m)Tc-REG in human lung cancer xenografts. Xie WH, Zhang B, Wang LH, Liu CY, Chang C, Lei B, Wu YW. Cancer Biother Radiopharm; 2015 Apr 05; 30(3):117-24. PubMed ID: 25714734 [Abstract] [Full Text] [Related] Page: [Next] [New Search]